Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach - PubMed (original) (raw)
Review
. 1989 Dec;38(12):1512-27.
doi: 10.2337/diab.38.12.1512.
Affiliations
- PMID: 2684710
- DOI: 10.2337/diab.38.12.1512
Review
Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach
R N Bergman. Diabetes. 1989 Dec.
Abstract
Glucose tolerance depends on a complex interaction among insulin secretion from the beta-cells, clearance of the hormone, and the actions of insulin to accelerate glucose disappearance and inhibit endogenous glucose production. An additional factor, less well recognized, is the ability of glucose per se, independent of changes in insulin, to increase glucose uptake and suppress endogenous output (glucose effectiveness). These factors can be measured in the intact organism with physiologically based minimal models of glucose utilization and insulin kinetics. With the glucose minimal model, insulin sensitivity (SI) and glucose effectiveness (SG) are measured by computer analysis of the frequently sampled intravenous glucose tolerance test. The test involves intravenous injection of glucose followed by tolbutamide or insulin and frequent blood sampling. SI varied from a high of 7.6 x 10(-4) min-1.microU-1.ml-1 in young Whites to 2.3 x 10(-4) min-1.microU-1.ml-1 in obese nondiabetic subjects; in all of the nondiabetic subjects, SG was normal. In subjects with non-insulin-dependent diabetes mellitus (NIDDM), not only was SI reduced 90% below normal (0.61 +/- 0.16 x 10(-4) min-1.microU-1.ml-1), but in this group alone, SG was reduced (from 0.026 +/- 0.008 to 0.014 +/- 0.002 min-1); thus, defects in SI and SG are synergistic in causing glucose intolerance in NIDDM. One assumption of the minimal model is that the time delay in insulin action on glucose utilization in vivo is due to sluggish insulin transport across the capillary endothelium. This was tested by comparing insulin concentrations in plasma with those in lymph (representing interstitial fluid) during euglycemic-hyperinsulinemic glucose clamps. Lymph insulin was lower than plasma insulin at basal (12 vs. 18 microU/ml) and at steady state, indicating significant loss of insulin from the interstitial space, presumably due to cellular uptake of the insulin-receptor complex. Additionally, during clamps, lymph insulin changed more slowly than plasma insulin, but the rate of glucose utilization followed a time course identical with that of lymph (r = .96) rather than plasma (r = .71). Thus, lymph insulin, which may be reflective of interstitial fluid, is the signal to which insulin-sensitive tissues are responding. These studies support the concept that, at physiological insulin levels, the time for insulin to cross the capillary endothelium is the process that determines the rate of insulin action in vivo.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model.
Bergman RN, Yang YJ, Hope ID, Ader M. Bergman RN, et al. Horm Metab Res Suppl. 1990;24:49-56. Horm Metab Res Suppl. 1990. PMID: 2272626 Review. - The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects.
Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al. Kahn SE, et al. Diabetes. 1994 Apr;43(4):587-92. doi: 10.2337/diab.43.4.587. Diabetes. 1994. PMID: 8138065 - Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.
Ader M, Pacini G, Yang YJ, Bergman RN. Ader M, et al. Diabetes. 1985 Nov;34(11):1092-103. doi: 10.2337/diab.34.11.1092. Diabetes. 1985. PMID: 2864297 - Toward an integrated phenotype in pre-NIDDM.
Bergman RN, Watanabe R, Rebrin K, Ader M, Steil G. Bergman RN, et al. Diabet Med. 1996 Sep;13(9 Suppl 6):S67-77. Diabet Med. 1996. PMID: 8894486 Review.
Cited by
- Influence of circadian phase and extended wakefulness on glucose levels during forced desynchrony.
Broussard JL, Knud-Hansen BC, Grady S, Knauer OA, Ronda JM, Aeschbach D, Czeisler CA, Wright KP Jr. Broussard JL, et al. Sleep Health. 2024 Feb;10(1S):S96-S102. doi: 10.1016/j.sleh.2023.10.010. Epub 2023 Nov 23. Sleep Health. 2024. PMID: 37996284 - Evaluating Deep Q-Learning Algorithms for Controlling Blood Glucose in In Silico Type 1 Diabetes.
Tejedor M, Hjerde SN, Myhre JN, Godtliebsen F. Tejedor M, et al. Diagnostics (Basel). 2023 Oct 7;13(19):3150. doi: 10.3390/diagnostics13193150. Diagnostics (Basel). 2023. PMID: 37835893 Free PMC article. - Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.
Cobelli C, Kovatchev B. Cobelli C, et al. J Diabetes Sci Technol. 2023 Nov;17(6):1493-1505. doi: 10.1177/19322968231195081. Epub 2023 Sep 25. J Diabetes Sci Technol. 2023. PMID: 37743740 Free PMC article. Review. - Methods for estimating insulin resistance from untargeted metabolomics data.
Hsu FC, Palmer ND, Chen SH, Ng MCY, Goodarzi MO, Rotter JI, Wagenknecht LE, Bancks MP, Bergman RN, Bowden DW. Hsu FC, et al. Metabolomics. 2023 Aug 9;19(8):72. doi: 10.1007/s11306-023-02035-5. Metabolomics. 2023. PMID: 37558891 Free PMC article. - Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research.
Casas B, Vilén L, Bauer S, Kanebratt KP, Wennberg Huldt C, Magnusson L, Marx U, Andersson TB, Gennemark P, Cedersund G. Casas B, et al. PLoS Comput Biol. 2022 Oct 19;18(10):e1010587. doi: 10.1371/journal.pcbi.1010587. eCollection 2022 Oct. PLoS Comput Biol. 2022. PMID: 36260620 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous